Role of pro-/anti-inflammatory cytokines and their correlation with established risk factors in south indians with coronary artery disease

Angiology

Volumn 60, Issue 4, 2009, Pages 419-426

  Rajappa, Medha ^a   Sen, S K ^b   Sharma, Alpana ^c  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b JAWAHARLAL INSTITUTE OF POSTGRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

^c ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Acute coronary syndromes; Acute myocardial infarction; Coronary artery disease; Interleukin 10; Interleukin 6; Interleukin 8; Pro anti inflammatory cytokines; Stable angina; Tumor necrosis factor alpha; Unstable angina

Indexed keywords

CHOLESTEROL; CYTOKINE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; AUTACOID; BIOLOGICAL MARKER; IL10 PROTEIN, HUMAN; IL6 PROTEIN, HUMAN; IL8 PROTEIN, HUMAN;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BLOOD PRESSURE; BODY MASS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY RISK; DIABETES MELLITUS; ENZYME LINKED IMMUNOSORBENT ASSAY; FAMILY HISTORY; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INDIAN; INFLAMMATION; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; SMOKING; STABLE ANGINA PECTORIS; STATISTICAL ANALYSIS; UNSTABLE ANGINA PECTORIS; ANGINA PECTORIS; BLOOD; CASE CONTROL STUDY; CAUCASIAN; COMPARATIVE STUDY; ETHNOLOGY; HEART INFARCTION; INDIA; MIDDLE AGED; RISK ASSESSMENT; RISK FACTOR;

AGED; ANGINA PECTORIS; ANGINA, UNSTABLE; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CORONARY ARTERY DISEASE; CYTOKINES; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; INDIA; INFLAMMATION MEDIATORS; INTERLEUKIN-10; INTERLEUKIN-6; INTERLEUKIN-8; MIDDLE AGED; MYOCARDIAL INFARCTION; RISK ASSESSMENT; RISK FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 70349566992     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/0003319708321101     Document Type: Article

References (59)

1. Tziakas DN, Chalikias GK, Hatzinikolaou HI, et al. Anti-inflammatory cytokine profile in acute coronary syndromes: behavior of interleukin-10 in association with serum metalloproteinases and proinflammatory cytokines. Int J Cardiol. 2003 ; 92: 169-175.
2. Mallika V., Goswami B., Rajappa M. Atherosclerosis pathophysiology and the role of novel risk factors: a clinicobiochemical perspective. Angiology. 2007 ; 58: 513-522.
3. Fuster V., Lewis A. Mechanisms leading to myocardial infarction: insights from studies of vascular biology. Circulation. 1994 ; 90: 2126-2146.
4. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993 ; 362: 801-809.
5. Falk E. Coronary thrombosis: pathogenesis and clinical manifestations. Am J Cardiol. 1991 ; 68 (Suppl B). 28B - 35B.
6. Fuster V., Badimon L., Badimon J., et al. The pathogenesis of coronary artery disease and acute coronary syndromes. N Engl J Med. 1992 ; 326: 242-250.
7. Shah PK Pathophysiology of unstable angina. Cardiol Clin. 1991 ; 9: 11-26.
8. El Fawal MA, Berg GA, Wheatley DJ, et al. Sudden coronary death in Glasgow: nature and frequency of acute coronary lesions. Br Heart J. 1987 ; 57: 329-335.
9. Maseri A. Inflammation, atherosclerosis, and ischemic events-exploring the hidden side of the moon. N Engl J Med. 1997 ; 336: 1014-1016.
10. Mendall MA, Patel P., Balloon L., et al. C-reactive protein and its relation to cardiovascular risk factors: a population based cross-sectional study. Br J Med. 1996 ; 312: 1061-1065.
11. Ridker P., Cushman M., Stampfel MJ, et al. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation. 1998 ; 97: 425-428.
12. Enas EA, Yusuf S., Mehta J. Prevalence of coronary artery disease in Asian Indians. Am J Cardiol. 1992 ; 70: 945-949.
13. Murray CJ, Lopez AD Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet. 1997 ; 349: 1498-1504.
14. Achari V., Thakur AK Association of major modifiable risk factors among patients with coronary artery disease- a retrospective analysis. J Assoc Physicians India. 2004 ; 52: 103-108.
15. McKeigue PM, Miller GJ, Marmot MG Coronary artery disease in South Asians overseas: a review. J Clin Epidemiol. 1989 ; 41: 597-598.
16. Begom R., Singh RB Prevalence of coronary artery disease and risk factors in urban population of south and north India. Acta Cardiol. 1995 ; 3: 227-240.
17. Davies MJ Reactive oxygen species, metalloproteinases, and plaque stability. Circulation. 1998 ; 97: 2382-2383.
18. Kai H., Ikeda H., Yasukawa H., et al. Peripheral blood levels of matrix metalloproteinases are elevated in patients with acute coronary syndromes. J Am Coll Cardiol. 1998 ; 32: 368-372.
19. Kim SH, Lee WH, Kwon BS, et al. Tumor necrosis factor receptor superfamily may destabilize atherosclerotic plaques by inducing matrix metalloproteinases. Jpn Circ J. 2001 ; 65: 136-138.
20. Kaartinen M., van der Wal AC, van der Loos CM, et al. Mast cell infiltration in acute coronary syndromes: implications for plaque rupture. J Am Coll Cardiol. 1998 ; 32: 606-612.
21. Mallat Z., Corbaz A., Scoazee A., et al. Expression of IL-18 in human atherosclerotic plaques and relation to plaque instability. Circulation. 2001 ; 104: 1598-1603.
22. Shah PK, Falk E., Badimon JJ, et al. Human macrophages induce breakdown of collagen in fibrous caps of atherosclerotic plaques. Potential role of matrix degrading metalloproteinases and implications for plaque rupture. J Am Coll Cardiol. 1998 ; 32: 606-612.
23. Li J., Guo Y., Yang Y. Enhancing anti-inflammatory cytokine IL-10 may be beneficial for acute coronary syndrome. Med Hypotheses. 2005 ; 65: 103-106.
24. Lacraz S., Nicod LP, Chicheportiche R., et al. IL-10 inhibits metalloproteinase and stimulates TIMP-1 production in human mononuclear phagocytes. J Clin Invest. 1995 ; 96: 2304-2310.
25. Mallat Z., Benard S., Durie ZM, et al. Protective role of interleukin-10 in atherosclerosis. Circ Res. 1999 ; 85: 17-24.
26. Rajappa M., Sharma A. An update on biomarkers of cardiac injury-a review. Angiology. 2005 ; 56: 677-691.
27. Rajappa M., Sridhar MG, Balachander J., et al. Lipoprotein (a) and comprehensive lipid tetrad index as a marker for coronary artery disease in NIDDM patients in south India. Clin Chim Acta. 2006 ; 372: 70-75.
28. Sharma A., Rajappa M., Saxena A., et al. Cytokine profile in Indian females with cervical intraepithelial neoplasia and cancer cervix. Int J Gynecol Cancer. 2007 ; 17: 879-885. (Pubitemid 47063332)
29. Corti R., Fuster V., Badimon JJ Pathogenic concepts of acute coronary syndromes. J Am Coll Cardiol. 2003 ; 41: 7S - 14S.
30. Hajjar DP, Haberland ME Lipoprotein trafficking in vascular cells: molecular Trojan horses and cellular saboteurs. J Biol Chem. 1997 ; 272: 22975-22978.
31. Paoletti R., Gotto AM Jr, Hajjar DP Inflammation in atherosclerosis and implications for therapy. Circulation. 2004 ; 109 (23 Suppl 1). 11120-11126.
32. Oren H., Erbay AR, Balci M., et al. Role of novel biomarkers of inflammation in patients with stable coronary heart disease. Angiology. 2007 ; 58: 148-155.
33. Otake H., Shite J., Shinke T., et al. Relation between plasma adiponectin, high-sensitivity C-reactive protein, and coronary plaque components in patients with acute coronary syndrome. Am J Cardiol. 2008 ; 101: 1-7.
34. Ridker PM Inflammatory biomarkers and risks of myocardial infarction, stroke, diabetes, and total mortality: implications for longevity. Nutr Rev. 2007 ; 65: S253 - S259.
35. Alam SE, Nasser SS, Fernainy KE, et al. Cytokine imbalance in acute coronary syndromes. Curr Opin Pharmacol. 2004 ; 4: 166-170.
36. Waehre R., Halvorsen B., Damas JK, et al. Inflammatory imbalance between IL-10 and TNF alpha in unstable angina: potential plaque stabilizing effects of IL-10. Eur J Clin Invest. 2002 ; 32: 803-810.
37. Pasqui AL, Di Renzo M., Bova G., et al. Proinflammatory/ anti-inflammatory cytokine imbalance in acute coronary syndromes. Clin Exp Med. 2006 ; 6: 38-44.
38. Smith DA, Irving SD, Sheldon J., et al. Serum levels of the anti-inflammatory cytokine interleukin-10 are decreased in patients with unstable angina. Circulation. 2001 ; 104: 746-749.
39. Mizia-Stec K., Gasior Z., Zahorska-Markiewicz B., et al. Serum tumor necrosis factor-alpha, interleukin-2 and interleukin-10 activation in stable angina and acute coronary syndromes. Coron Artery Dis. 2003 ; 14: 431-438. (Pubitemid 37070321)
40. Shibata M., Endo S., Imada K., et al. Elevated levels of interleukin-1 receptor antagonist and interleukin-10 in patients with acute myocardial infarction. J Interferon Cytokine Res. 1997 ; 17 145-150.
41. Szodoray1 P., Timar O., Veres K., et al. Th1/Th2 imbalance, measured by circulating and intracytoplasmic inflammatory cytokines-immunological alterations in acute coronary syndrome and stable coronary artery disease. Scand J Immunol. 2006 ; 64: 336-344.
42. Wang P., Wu P., Siegel MI, et al. Interleukin-10 inhibits nuclear factors-?°?2 (NF-?°?2) activation in human monocytes. J Biol Chem. 1995 ; 270: 9558-9563.
43. Lentsch AB, Shanley TP, Sharma V., et al. In vivo suppression of NF-?°?2 and preservation of IKB by interleukin-10 and interleukin-13. J Clin Invest. 1997 ; 100: 2443-2448.
44. Mertz PM, Dewitt DL, Stetlerstevenson WG, et al. Interleukin-10 suppression of monocyte prostaglandin-H synthase-2: mechanism of prostaglandin-dependent matrix metalloproteinase production. J Biol Chem. 1994 ; 269: 21322-21329.
45. Arai T., Hiromatsu K., Nishimura H., et al. Endogenous IL-10 prevents apoptosis in macrophages during salmonella infection. Biochem Biophys Res Commun. 1995 ; 213: 600-607.
46. Cohen SB, Crawley JB, Mohan MC, et al. Interleukin-10 rescues cells from apoptotic cell death: association with an upregulation of Bcl-2. Immunology. 1997 ; 92: 1-5.
47. Xang Z., Zingerelli B., Szabo C. Crucial role of endogenous interleukin production in myocardial ischemia/ reperfusion injury. Circulation. 2000 ; 101: 1019-1026.
48. Frangogiannis NG, Smith W., Entman ML The inflammatory response in myocardial infarction. Cardiovasc Res. 2002 ; 53: 31-47.
49. Silvestre J., Mallat Z., Duriez M., et al. Anti-angiogenic effect of interleukin-10 in ischemia-induced angiogenesis in mice hindlimb. Circ Res. 2000 ; 87: 448-452.
50. Luo Y., Jiang D., Wen D., et al. Changes in serum interleukin-6 and C-reactive protein levels in patients with acute coronary syndromes. Heart Vessels. 2004 ; 19: 257-262.
51. Balbay Y., Tikiz H., Baptiste RJ, et al. Circulating IL-1 beta, IL-6, TNF-alpha and soluble ICAM-1 in patients with acute coronary syndromes. Angiology. 2001 ; 52: 109-114.
52. Koukkunen H., Penttila K., Kemppainen A., et al. C-reactive protein, fibrinogen, IL-6, and TNF-alpha in the prognostic classification of unstable angina pectoris. Ann Med. 2001 ; 33: 37-47.
53. Wang YN, Che SM, Ma HQ Clinical significance of IL-1 beta, sIL-2R, IL-6, TNF-alpha and IFN-gamma in acute coronary syndromes. Chin Med Sci J. 2004 ; 19: 120-124.
54. Finkel M., Oddis CV, Jacob TD, et al. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science. 1992 ; 257: 387-389.
55. Tousoulis D., Davies G., Stefanadis C., et al. Inflammatory and thrombotic mechanisms in coronary atherosclerosis. Heart. 2003 ; 89: 993-997.
56. Brueckmann M., Bertsch T., Lang S., et al. Time course of systemic markers of inflammation in patients presenting with acute coronary syndromes. Clin Chem Lab Med. 2004 ; 42: 1132-1139.
57. Pinderski OLJ, Hedrick CC, Olvera T., et al. Interleukin-10 blocks atherosclerotic events in vitro and in vivo. Arterioscler Thromb Vasc Biol. 1999 ; 19: 2847-2853.
58. Tarkeltaub RA IL-10 an immunological scalpel for atherosclerosis. Arterioscler Thromb Vasc Biol. 1999 ; 19: 2823-2825.
59. Durrington PN Triglycerides are more important than epidemiology has suggested. Atherosclerosis. 1998 ; 141 (Suppl 1). S57 - S62.